TG Therapeutics (TGTX) announced that it has completed its previously authorized $100M share repurchase program, which was initially announced in August 2024. Under that program, the Company ...
STAMFORD, Conn.--(BUSINESS WIRE)--HealthCare Royalty (“HCRx”), in conjunction with funds managed by Blue Owl Capital (“Blue Owl”), has entered into a $250 million term loan facility (the “Initial Term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback